Treatment of organ transplantation rejection

Details Treatment of organ transplantation rejection Treatment of organ transplantation rejection

A - Human Necessities

61

K

A61K 31/47 (2006.01) A61K 31/52 (2006.01) A61K 31/557 (2006.01) A61K 38/13 (2006.01)

Patent

CA 2085002

2085002 9119498 PCTABS00008 4-Quinoline-carboxylic acid derivatives, such as 2-(2'-fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinoline carboxylic acid, in combination with other immunosuppressive agents are useful for the treatment and/or prevention of transplantation rejection, graft vs. host disease, autoimmune diseases, and chronic inflammatory disease.

Affiliated with

Also associated with

Rating

Treatment of organ transplantation rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of organ transplantation rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of organ transplantation rejection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1931993